Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world†but would also be a massive growth engine for the country.COVID-19 could give momentum to Indian healthcare industry: HUL CMD Sanjiv Mehta
Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world†but would also be a massive growth engine for the country.
Subscribe to:
Post Comments (Atom)
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
No comments:
Post a Comment